Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 9/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 9/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 9/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 9/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 9/20 | 0.32 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27850168 | 0.88 | ATM (0.33) | ATMCHRNB2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL6703644 | 0.82 | SSTR4 (0.32) | ATM | |
| SCHEMBL27896513 | 0.82 | NOS2 (0.36) | ATMCHRM2CHRM1CHRM3 | |
| SCHEMBL5969030 | 0.81 | LMNA (0.34) | ATMCHRNB2CHRNB4CHRNA3CHRNA7 | |
| Piperazine SCHEMBL17912476 | 0.80 | DGAT1 (0.33) | ATMMAOAMAOB | |
| SCHEMBL28812753 | 0.80 | KDM4E (0.31) | ATM | |
| SCHEMBL28902273 | 0.79 | DGAT1 (0.42) | ATMMAOAMAOBCHRM2CHRM1 | |
| SCHEMBL30234788 | 0.79 | DGAT1 (0.42) | ATMMAOAMAOBCHRM2CHRM1 | |
| SCHEMBL28325001 | 0.79 | DGAT1 (0.42) | ATMMAOAMAOBCHRM2CHRM1 | |
| SCHEMBL3094 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101128199-B | Monocyclic heterocycles as kinase inhibitors | BRISTOL MYERS SQUIBB CO | 2013-07-24 | — | — | CN | disclosed |
| CN-101426486-A | Compounds for the treatment of inflammatory disorders and microbial diseases | SCHERING CORP (US) | 2009-05-06 | — | — | CN | disclosed |
| CN-101128199-A | Monocyclic heterocycles as kinase inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2008-02-20 | — | — | CN | disclosed |
| CN-101027295-A | Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders | SCHERING CORP (US) | 2007-08-29 | — | — | CN | disclosed |